Global NK Cell Therapy Market Research Report 2019

Table of Contents

Executive Summary

1 NK Cell Therapy Market Overview

• 1.1 Product Overview and Scope of NK Cell Therapy
• 1.2 NK Cell Therapy Segment by Type
  • 1.2.1 Global NK Cell Therapy Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Mogamulizumab
  • 1.2.3 Lorvotuzumab Mertansine
  • 1.2.4 Others
• 1.3 NK Cell Therapy Segment by Application
  • 1.3.1 NK Cell Therapy Consumption Comparison by Application (2014-2025)
  • 1.3.2 Cancer
  • 1.3.3 Cardiovascular Diseases
  • 1.3.4 Others
• 1.4 Global NK Cell Therapy Market by Region
  • 1.4.1 Global NK Cell Therapy Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global NK Cell Therapy Market Size
  • 1.5.1 Global NK Cell Therapy Revenue (2014-2025)
  • 1.5.2 Global NK Cell Therapy Production (2014-2025)

2 Global NK Cell Therapy Market Competition by Manufacturers

• 2.1 Global NK Cell Therapy Production Market Share by Manufacturers (2014-2019)
• 2.2 Global NK Cell Therapy Revenue Share by Manufacturers (2014-2019)
• 2.3 Global NK Cell Therapy Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers NK Cell Therapy Production Sites, Area Served, Product Types
• 2.5 NK Cell Therapy Market Competitive Situation and Trends
  • 2.5.1 NK Cell Therapy Market Concentration Rate
  • 2.5.2 NK Cell Therapy Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global NK Cell Therapy Production Market Share by Regions

• 3.1 Global NK Cell Therapy Production Market Share by Regions
• 3.2 Global NK Cell Therapy Revenue Market Share by Regions (2014-2019)
• 3.3 Global NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America NK Cell Therapy Production
  • 3.4.1 North America NK Cell Therapy Production Growth Rate (2014-2019)
  • 3.4.2 North America NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe NK Cell Therapy Production
  • 3.5.1 Europe NK Cell Therapy Production Growth Rate (2014-2019)
  • 3.5.2 Europe NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China NK Cell Therapy Production (2014-2019)
  • 3.6.1 China NK Cell Therapy Production Growth Rate (2014-2019)
  • 3.6.2 China NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan NK Cell Therapy Production (2014-2019)
  • 3.7.1 Japan NK Cell Therapy Production Growth Rate (2014-2019)
  • 3.7.2 Japan NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)

4 Global NK Cell Therapy Consumption by Regions

• 4.1 Global NK Cell Therapy Consumption by Regions
• 4.2 North America NK Cell Therapy Consumption (2014-2019)
• 4.3 Europe NK Cell Therapy Consumption (2014-2019)
• 4.4 China NK Cell Therapy Consumption (2014-2019)
• 4.5 Japan NK Cell Therapy Consumption (2014-2019)

5 Global NK Cell Therapy Production, Revenue, Price Trend by Type

• 5.1 Global NK Cell Therapy Production Market Share by Type (2014-2019)
• 5.2 Global NK Cell Therapy Revenue Market Share by Type (2014-2019)
• 5.3 Global NK Cell Therapy Price by Type (2014-2019)
• 5.4 Global NK Cell Therapy Production Growth by Type (2014-2019)

6 Global NK Cell Therapy Market Analysis by Applications

• 6.1 Global NK Cell Therapy Consumption Market Share by Application (2014-2019)
• 6.2 Global NK Cell Therapy Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in NK Cell Therapy Business

• 7.1 Chipscreen Biosciences (China)
  • 7.1.1 Chipscreen Biosciences (China) NK Cell Therapy Production Sites and Area Served
  • 7.1.2 NK Cell Therapy Product Introduction, Application and Specification
  • 7.1.3 Chipscreen Biosciences (China) NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Affimed NV (Netherlands)
  • 7.2.1 Affimed NV (Netherlands) NK Cell Therapy Production Sites and Area Served
  • 7.2.2 NK Cell Therapy Product Introduction, Application and Specification
  • 7.2.3 Affimed NV (Netherlands) NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Altor BioScience Corporation (USA)
  • 7.3.1 Altor BioScience Corporation (USA) NK Cell Therapy Production Sites and Area Served
  • 7.3.2 NK Cell Therapy Product Introduction, Application and Specification
  • 7.3.3 Altor BioScience Corporation (USA) NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Innate Pharma SA (France)
  • 7.4.1 Innate Pharma SA (France) NK Cell Therapy Production Sites and Area Served
  • 7.4.2 NK Cell Therapy Product Introduction, Application and Specification
  • 7.4.3 Innate Pharma SA (France) NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Takeda Pharmaceutical (Japan)
  • 7.5.1 Takeda Pharmaceutical (Japan) NK Cell Therapy Production Sites and Area Served
  • 7.5.2 NK Cell Therapy Product Introduction, Application and Specification
  • 7.5.3 Takeda Pharmaceutical (Japan) NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Sorrento Therapeutics Inc. (USA)
  • 7.6.1 Sorrento Therapeutics Inc. (USA) NK Cell Therapy Production Sites and Area Served
  • 7.6.2 NK Cell Therapy Product Introduction, Application and Specification
  • 7.6.3 Sorrento Therapeutics Inc. (USA) NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 NantKwest Inc. (USA)
  • 7.7.1 NantKwest Inc. (USA) NK Cell Therapy Production Sites and Area Served
  • 7.7.2 NK Cell Therapy Product Introduction, Application and Specification
  • 7.7.3 NantKwest Inc. (USA) NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Bristol-Myers Squibb (USA)
  • 7.8.1 Bristol-Myers Squibb (USA) NK Cell Therapy Production Sites and Area Served
  • 7.8.2 NK Cell Therapy Product Introduction, Application and Specification
  • 7.8.3 Bristol-Myers Squibb (USA) NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 NKT Therapeutics (USA)
  • 7.9.1 NKT Therapeutics (USA) NK Cell Therapy Production Sites and Area Served
  • 7.9.2 NK Cell Therapy Product Introduction, Application and Specification
  • 7.9.3 NKT Therapeutics (USA) NK Cell Therapy Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served

8 NK Cell Therapy Manufacturing Cost Analysis

• 8.1 NK Cell Therapy Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of NK Cell Therapy
• 8.4 NK Cell Therapy Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 NK Cell Therapy Distributors List
• 9.3 NK Cell Therapy Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global NK Cell Therapy Market Forecast

• 11.1 Global NK Cell Therapy Production, Revenue Forecast
  • 11.1.1 Global NK Cell Therapy Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global NK Cell Therapy Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global NK Cell Therapy Price and Trend Forecast (2019-2025)
• 11.2 Global NK Cell Therapy Production Forecast by Regions (2019-2025)
  • 11.2.1 North America NK Cell Therapy Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe NK Cell Therapy Production, Revenue Forecast (2019-2025)
  • 11.2.3 China NK Cell Therapy Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan NK Cell Therapy Production, Revenue Forecast (2019-2025)
• 11.3 Global NK Cell Therapy Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America NK Cell Therapy Consumption Forecast (2019-2025)
  • 11.3.2 Europe NK Cell Therapy Consumption Forecast (2019-2025)
  • 11.3.3 China NK Cell Therapy Consumption Forecast (2019-2025)
  • 11.3.4 Japan NK Cell Therapy Consumption Forecast (2019-2025)
• 11.4 Global NK Cell Therapy Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global NK Cell Therapy Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List